Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a 5-Session therapy help teens with PTSD?

NCT ID NCT07498257

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

This study adapts Written Exposure Therapy (WET), a brief 5-session treatment, for adolescents aged 12-18 with PTSD. Researchers will first gather feedback from experts and teens, then test the adapted therapy against the standard 12-16 session treatment in 48 teens. The goal is to see if this shorter therapy works as well and is more accessible for young people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2026

Expected to finish

Feb 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Aim 1 (Obj. 1.1) Inclusion Criteria for Adolescents with PTSD: 1. Between the ages of 12 through 18 years old. 18-year-old participants who turn 18 after the date in which they consent to participate may participate, but may not enroll in the study if already at the age of 19. 2. Accompanying, consenting caregiver (exception, 18-year-olds can provide consent without accompanying caregiver) 3. Exposure to one or more potentially traumatic event(s) on the NCVTRC clinic phone screen. 4. Ability to comprehend English. 5. A score of greater than or equal to 6 on the Child Trauma Screen (CTS) 6. Residence in the state of South Carolina. Aim 1 (Obj. 1.1) Exclusion Criteria for Adolescents with PTSD: 1. Active psychosis, bipolar disorder, or a comorbid condition that requires a higher level of immediate care (e.g., anorexia nervosa, alcohol withdrawal). 2. Active suicide risk with ideation, plan and intent. 3. Active, ongoing violence, abuse, or other ongoing traumatic events that indicate immediate safety concerns. 4. Children in foster care, kinship care, or with active Department of Social Services (DSS) investigations. 5. History of pervasive developmental or intellectual disability. 6. Any other medical or psychiatric condition that compromise the participant's ability to safely participate. 7. Inability or unwillingness of the caregiver to consent for adolescent to participate (exception, 18-year-olds can provide consent without accompanying caregiver). Aim 1 (Obj. 1.1) Inclusion Criteria for PTSD Treatment Providers: 1. Masters-level degree or higher in psychology or a related discipline (e.g., social work; counseling). 2. Current provider of trauma-focused treatment to adolescents with PTSD in an outpatient setting for a minimum of one year. 3. Ability to comprehend English. 4. Consent to participate in a one time study visit. Aim 1 (Obj 1.1) Inclusion Criteria for Pediatric Primary Care Mental Health Providers: 1. Masters-level degree or higher in psychology or a related discipline (e.g., social work; counseling). 2. Current status as a mental health clinician housed in an integrated pediatric primary care setting. 3. Ability to comprehend English. 4. Consent to participate in a one-time study visit. There are no exclusion criteria for Aim 1 Providers. Aim 1 (Obj 1.2 theater testing) and Aim 2 (RCT) Inclusion Criteria for Adolescents with PTSD: 1. Adolescent between the ages of 12 through 18 years old. 18-year-old participants who turn 18 after the date in which they consent to participate may participate, but may not enroll in the study if already at the age of 19. 2. Accompanying consenting caregiver (exception, 18-year-olds can provide consent without accompanying caregiver) 3. Endorsement of one or more exposure to past potentially traumatic event(s). Trauma event(s) must have occurred over one-month ago, per DSM-5 criteria. 4. Ability to comprehend English. 5. A score of greater than or equal to 21 on the Child and Adolescent Trauma Screen (CATS). 6. Residence in the state of South Carolina. Aim 1 (Obj 1.2 theater testing) and Aim 2 (RCT) Exclusion Criteria for Adolescents with PTSD: 1. Active psychosis, bipolar disorder, or a comorbid condition that requires a higher level of immediate care (e.g., anorexia nervosa, alcohol withdrawal). 2. Active suicide risk with ideation, plan and intent. 3. Active, ongoing violence, abuse, or other ongoing traumatic events that indicate immediate safety concerns. 4. Children in foster care, kinship care, or with active DSS investigations. 5. History of pervasive developmental or intellectual disability. 6. Any other medical or psychiatric condition that compromise the participant's ability to safely participate. 7. Inability or unwillingness of caregiver to consent for adolescent to participate (exception, 18-year-olds can participate without an accompanying caregiver). 8. Lack of any memory of the traumatic event(s). 9. Individuals psychotropic medications must be stabilized on the medication for at least two weeks prior to study start date. Recruitment will not include special classes of subjects such as prisoners, pregnant women, or institutional individuals.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Posttraumatic stress disorder (PTSD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina National Crime Victims Research and Treatment Center

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.